Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (Mangoral) and Oncoral – in clinical development. Ascelia Pharma has its global headquarters in Malmö, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE). For more information, please visit www.ascelia.com.
At Ascelia Pharma you will have the opportunity to join an ambitious and dedicated orphan-oncology company and be part of the journey to build a global life science organization.
If you submit your resume, we will review your information and contact you if any relevant positions become available.
.
What we offer
At Ascelia Pharma, your skills, dedication, and engagement help us improve the lives of people living with cancer. We offer you an opportunity to be part of a fast-growing company with global reach, where engagement, dedication and results are met with opportunities for individual and professional development.
Join us on our journey to improve patients’ lives and build a global orphan oncology life science organization.
Ascelia Pharma currently has two drug candidates – Orviglance and Oncoral – in clinical development. You can read more about them here.
